TOLERANCE INDUCTION TO CULTURED ISLET ALLOGRAFTS .2. THE STATUS OF ANTIDONOR REACTIVITY IN TOLERANT ANIMALS

Citation
M. Coulombe et Rg. Gill, TOLERANCE INDUCTION TO CULTURED ISLET ALLOGRAFTS .2. THE STATUS OF ANTIDONOR REACTIVITY IN TOLERANT ANIMALS, Transplantation, 57(8), 1994, pp. 1201-1207
Citations number
46
Categorie Soggetti
Immunology,Surgery
Journal title
ISSN journal
00411337
Volume
57
Issue
8
Year of publication
1994
Pages
1201 - 1207
Database
ISI
SICI code
0041-1337(1994)57:8<1201:TITCIA>2.0.ZU;2-H
Abstract
Murine islet tissue cultured in 95% O-2 to eliminate/inactivate donor antigen-presenting cells can function indefinitely and induce a state of tolerance in nonimmunosuppressed, allogeneic recipients. Such cultu red grafts represent a model of antigen presentation in which antigen (signal 1) is presented without the delivery of appropriate costimulat ory activity (signal 2) necessary for T cell activation. As T cell ina ctivation has been proposed to result from this form of antigen presen tation, we determined whether the tolerance generated in response to s uch cultured grafts was due to a passive (clonal deletion/inactivation ) mechanism. We have shown that, although tolerant in vivo, animals be aring long-term cultured islet allografts are donorreactive in vitro a s assessed by (1) CTL precursor frequency, (2) antidonor proliferative and cytotoxic responses, and (3) lymphokine production (IL-2, IL-3, T NF, and IFN-gamma). In addition, tolerance does not appear to be tissu e (islet)-specific in that primed, donor-reactive T cells from toleran t animals react to islet cells in vitro and are capable of destroying donor-type islet grafts in vivo. Thus, the notion that ''signal 1'' an tigen presentation, as represented by cultured islet allografts, leads to the clonal deletion or inactivation (anergy) of donor-reactive T c ells is not supported by these results. Since this form of tolerance d oes not appear to be an intrinsic property of the donor-specific lymph ocyte, these results are more consistent with a model of active regula tory tolerance in vivo.